Growth Metrics

Eli Lilly (LLY) Cash from Investing Activities (2016 - 2025)

Eli Lilly's Cash from Investing Activities history spans 17 years, with the latest figure at -$2.8 billion for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 45.87% year-over-year to -$2.8 billion; the TTM value through Dec 2025 reached -$11.0 billion, down 17.95%, while the annual FY2025 figure was -$11.0 billion, 17.95% down from the prior year.
  • Cash from Investing Activities reached -$2.8 billion in Q4 2025 per LLY's latest filing, up from -$3.0 billion in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$459.1 million in Q2 2023 to a low of -$4.0 billion in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$1.7 billion, with a median of -$1.2 billion recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: surged 44.45% in 2023, then tumbled 378.92% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$484.2 million in 2021, then crashed by 94.86% to -$943.5 million in 2022, then plummeted by 209.97% to -$2.9 billion in 2023, then skyrocketed by 34.32% to -$1.9 billion in 2024, then plummeted by 45.87% to -$2.8 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Cash from Investing Activities are -$2.8 billion (Q4 2025), -$3.0 billion (Q3 2025), and -$1.8 billion (Q2 2025).